GBG 96 GeparDouze
NSABP B-59/GBG-96-GeparDouze: Phase III Trial of Neoadjuvant CT Plus Atezolizumab Followed by Adjuvant Atezolizumab for Stage II/III TNBC

Released: December 18, 2024

Expiration: December 16, 2025

Activity

Progress
1
Course Completed